{"id":32922,"date":"2014-10-07T08:00:29","date_gmt":"2014-10-07T12:00:29","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=32922"},"modified":"2014-10-07T08:00:29","modified_gmt":"2014-10-07T12:00:29","slug":"trending-stocks-alcobra-ltd-nasdaqadhd-tekmira-pharmaceuticals-corporation-nasdaqtkmr-radioshack-corporation-nysersh","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-alcobra-ltd-nasdaqadhd-tekmira-pharmaceuticals-corporation-nasdaqtkmr-radioshack-corporation-nysersh-32922","title":{"rendered":"Trending Stocks: Alcobra Ltd (NASDAQ:ADHD); Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR), RadioShack Corporation (NYSE:RSH)"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 10\/07\/2014 (wallstreetpr) \u2013 Pharma firm Alcobra Ltd (NASDAQ:ADHD) <a href=\"http:\/\/finance.yahoo.com\/news\/alcobra-announces-topline-results-phase-100000802.html\">announced<\/a> on 6th October that its phase three tests on its drug candidate Metadoxine to treat Attention Deficit Hyperactivity Disorder. The drug maker announced that the results have indicated that the \u201cextended release\u201d approach of administering the drug to adults which is being experimented has showed positive results. Following the announcement, Alcobra Ltd (NASDAQ:ADHD) President and Chief Executive Officer announced that his R&amp;D team will derive encouragement from the findings. He further expressed happiness that the study did not get embroiled in \u201csafety and tolerability issues\u201d that such tests generally run into during clinical trials.<\/p>\n<p style=\"text-align: justify;\">Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) <a href=\"http:\/\/www.marketwatch.com\/story\/tekmira-shares-slump-as-leerink-downgrades-on-valuation-grounds-2014-10-06?siteid=yhoof2\">saw<\/a> a huge slide in its share price during trading on 6th October after analysts at rating house Leerink downgraded the stock. The new rating has been pegged at market perform from previous recommendation of outperform. The downgrade comes even as the company stock has been gaining on the back of the huge potential the drug maker would enjoy in the event of its test drug designed to treat the dreaded Ebola virus gets approved. The company stock had sky rocketed over the past 60 days after it emerged that its test drug had been used to treat one of the compromised American patient.<\/p>\n<p style=\"text-align: justify;\">RadioShack Corporation (NYSE:RSH) stock saw a double digit <a href=\"http:\/\/www.bloomberg.com\/news\/2014-10-06\/radioshack-rescue-package-decried-as-stopgap-measure.html?cmpid=yhoo\">percentage<\/a> slide yesterday after investors and analysts alike, discounted the likely long term positive impact of the financing package the electronics retailer announced last week. The analysts have pointed out that the short term debt raised by the retailer from one of its existing customer is more likely going to be a stop gap arrangement, rather than a long lasting solution for the cash flow problems RadioShack Corporation (NYSE:RSH) is facing. Standard General LP which has emerged as one of the biggest investors in the embattled firm had last week announced that it is refinancing a $535 million loan in order to help the firm meet its immediate debt burden.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 10\/07\/2014 (wallstreetpr) \u2013 Pharma firm Alcobra Ltd (NASDAQ:ADHD) announced on 6th October that its phase three tests on its drug candidate Metadoxine to [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":32925,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[2236],"tags":[8172,4366,4367,4911,1253,1378,4857,8020,4910],"stock_ticker":[],"class_list":["post-32922","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","tag-alcobra-ltd","tag-alcobra-ltd-nasdaqadhd","tag-nasdaqadhd","tag-nasdaqtkmr","tag-nysersh","tag-radioshack-corporation","tag-radioshack-corporation-nysersh","tag-tekmira-pharmaceuticals-corporation","tag-tekmira-pharmaceuticals-corporation-nasdaqtkmr","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Trending Stocks: Alcobra Ltd (NASDAQ:ADHD); Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR), RadioShack Corporation (NYSE:RSH) - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-alcobra-ltd-nasdaqadhd-tekmira-pharmaceuticals-corporation-nasdaqtkmr-radioshack-corporation-nysersh-32922\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Trending Stocks: Alcobra Ltd (NASDAQ:ADHD); Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR), RadioShack Corporation (NYSE:RSH) - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 10\/07\/2014 (wallstreetpr) \u2013 Pharma firm Alcobra Ltd (NASDAQ:ADHD) announced on 6th October that its phase three tests on its drug candidate Metadoxine to [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-alcobra-ltd-nasdaqadhd-tekmira-pharmaceuticals-corporation-nasdaqtkmr-radioshack-corporation-nysersh-32922\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-10-07T12:00:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Greg Folin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Greg Folin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-alcobra-ltd-nasdaqadhd-tekmira-pharmaceuticals-corporation-nasdaqtkmr-radioshack-corporation-nysersh-32922#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-alcobra-ltd-nasdaqadhd-tekmira-pharmaceuticals-corporation-nasdaqtkmr-radioshack-corporation-nysersh-32922\"},\"author\":{\"name\":\"Greg Folin\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\"},\"headline\":\"Trending Stocks: Alcobra Ltd (NASDAQ:ADHD); Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR), RadioShack Corporation (NYSE:RSH)\",\"datePublished\":\"2014-10-07T12:00:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-alcobra-ltd-nasdaqadhd-tekmira-pharmaceuticals-corporation-nasdaqtkmr-radioshack-corporation-nysersh-32922\"},\"wordCount\":349,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-alcobra-ltd-nasdaqadhd-tekmira-pharmaceuticals-corporation-nasdaqtkmr-radioshack-corporation-nysersh-32922#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg\",\"keywords\":[\"Alcobra Ltd\",\"Alcobra Ltd (NASDAQ:ADHD)\",\"NASDAQ:ADHD\",\"NASDAQ:TKMR\",\"NYSE:RSH\",\"RadioShack Corporation\",\"RadioShack Corporation (NYSE:RSH)\",\"Tekmira Pharmaceuticals Corporation\",\"Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR)\"],\"articleSection\":[\"Business\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-alcobra-ltd-nasdaqadhd-tekmira-pharmaceuticals-corporation-nasdaqtkmr-radioshack-corporation-nysersh-32922#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-alcobra-ltd-nasdaqadhd-tekmira-pharmaceuticals-corporation-nasdaqtkmr-radioshack-corporation-nysersh-32922\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-alcobra-ltd-nasdaqadhd-tekmira-pharmaceuticals-corporation-nasdaqtkmr-radioshack-corporation-nysersh-32922\",\"name\":\"Trending Stocks: Alcobra Ltd (NASDAQ:ADHD); Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR), RadioShack Corporation (NYSE:RSH) - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-alcobra-ltd-nasdaqadhd-tekmira-pharmaceuticals-corporation-nasdaqtkmr-radioshack-corporation-nysersh-32922#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-alcobra-ltd-nasdaqadhd-tekmira-pharmaceuticals-corporation-nasdaqtkmr-radioshack-corporation-nysersh-32922#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg\",\"datePublished\":\"2014-10-07T12:00:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-alcobra-ltd-nasdaqadhd-tekmira-pharmaceuticals-corporation-nasdaqtkmr-radioshack-corporation-nysersh-32922#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-alcobra-ltd-nasdaqadhd-tekmira-pharmaceuticals-corporation-nasdaqtkmr-radioshack-corporation-nysersh-32922\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-alcobra-ltd-nasdaqadhd-tekmira-pharmaceuticals-corporation-nasdaqtkmr-radioshack-corporation-nysersh-32922#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg\",\"width\":1024,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-alcobra-ltd-nasdaqadhd-tekmira-pharmaceuticals-corporation-nasdaqtkmr-radioshack-corporation-nysersh-32922#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Trending Stocks: Alcobra Ltd (NASDAQ:ADHD); Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR), RadioShack Corporation (NYSE:RSH)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\",\"name\":\"Greg Folin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"caption\":\"Greg Folin\"},\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Trending Stocks: Alcobra Ltd (NASDAQ:ADHD); Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR), RadioShack Corporation (NYSE:RSH) - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-alcobra-ltd-nasdaqadhd-tekmira-pharmaceuticals-corporation-nasdaqtkmr-radioshack-corporation-nysersh-32922","og_locale":"en_US","og_type":"article","og_title":"Trending Stocks: Alcobra Ltd (NASDAQ:ADHD); Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR), RadioShack Corporation (NYSE:RSH) - Wall Street PR","og_description":"Boston, MA 10\/07\/2014 (wallstreetpr) \u2013 Pharma firm Alcobra Ltd (NASDAQ:ADHD) announced on 6th October that its phase three tests on its drug candidate Metadoxine to [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-alcobra-ltd-nasdaqadhd-tekmira-pharmaceuticals-corporation-nasdaqtkmr-radioshack-corporation-nysersh-32922","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-10-07T12:00:29+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg","type":"image\/jpeg"}],"author":"Greg Folin","twitter_misc":{"Written by":"Greg Folin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-alcobra-ltd-nasdaqadhd-tekmira-pharmaceuticals-corporation-nasdaqtkmr-radioshack-corporation-nysersh-32922#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-alcobra-ltd-nasdaqadhd-tekmira-pharmaceuticals-corporation-nasdaqtkmr-radioshack-corporation-nysersh-32922"},"author":{"name":"Greg Folin","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e"},"headline":"Trending Stocks: Alcobra Ltd (NASDAQ:ADHD); Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR), RadioShack Corporation (NYSE:RSH)","datePublished":"2014-10-07T12:00:29+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-alcobra-ltd-nasdaqadhd-tekmira-pharmaceuticals-corporation-nasdaqtkmr-radioshack-corporation-nysersh-32922"},"wordCount":349,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-alcobra-ltd-nasdaqadhd-tekmira-pharmaceuticals-corporation-nasdaqtkmr-radioshack-corporation-nysersh-32922#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg","keywords":["Alcobra Ltd","Alcobra Ltd (NASDAQ:ADHD)","NASDAQ:ADHD","NASDAQ:TKMR","NYSE:RSH","RadioShack Corporation","RadioShack Corporation (NYSE:RSH)","Tekmira Pharmaceuticals Corporation","Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR)"],"articleSection":["Business"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-alcobra-ltd-nasdaqadhd-tekmira-pharmaceuticals-corporation-nasdaqtkmr-radioshack-corporation-nysersh-32922#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-alcobra-ltd-nasdaqadhd-tekmira-pharmaceuticals-corporation-nasdaqtkmr-radioshack-corporation-nysersh-32922","url":"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-alcobra-ltd-nasdaqadhd-tekmira-pharmaceuticals-corporation-nasdaqtkmr-radioshack-corporation-nysersh-32922","name":"Trending Stocks: Alcobra Ltd (NASDAQ:ADHD); Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR), RadioShack Corporation (NYSE:RSH) - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-alcobra-ltd-nasdaqadhd-tekmira-pharmaceuticals-corporation-nasdaqtkmr-radioshack-corporation-nysersh-32922#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-alcobra-ltd-nasdaqadhd-tekmira-pharmaceuticals-corporation-nasdaqtkmr-radioshack-corporation-nysersh-32922#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg","datePublished":"2014-10-07T12:00:29+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-alcobra-ltd-nasdaqadhd-tekmira-pharmaceuticals-corporation-nasdaqtkmr-radioshack-corporation-nysersh-32922#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-alcobra-ltd-nasdaqadhd-tekmira-pharmaceuticals-corporation-nasdaqtkmr-radioshack-corporation-nysersh-32922"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-alcobra-ltd-nasdaqadhd-tekmira-pharmaceuticals-corporation-nasdaqtkmr-radioshack-corporation-nysersh-32922#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg","width":1024,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-alcobra-ltd-nasdaqadhd-tekmira-pharmaceuticals-corporation-nasdaqtkmr-radioshack-corporation-nysersh-32922#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Trending Stocks: Alcobra Ltd (NASDAQ:ADHD); Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR), RadioShack Corporation (NYSE:RSH)"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e","name":"Greg Folin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","caption":"Greg Folin"},"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/32922","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=32922"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/32922\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/32925"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=32922"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=32922"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=32922"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=32922"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}